Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. ultraeasy

UltraEASY

Computer Aided Multispectral Ulstrasound Diagnostic Device

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 UltraEASY project word cloud

Explore the words cloud of the UltraEASY project. It provides you a very rough idea of what is the project "UltraEASY" about.

amounts    europeans    conduct    clinical    family    regard    multiple    brain    stroke    computer    market    practices    feedback    events    thanks    fast    conclude    eur    sonovum    specialist    economic    precise    evaluation    suffers    camud    wake    frame    therapeutic    continuous    patient    beginning    feasibility    medtech    vitals    waves    underlying    physicians    flexibility    suited    acute    vehicles    trade    someone    tissue    strategies    emergency    seconds    diagnostic    immense    ag    realization    modern    examination    diagnose    daily    risk    time    every    harmful    small    incidents    stands    carriers    36    patients    ultraeasy    2006    units    helicopters    ultrasound    ambulances    killing    therewith    aided    interpretable    monitoring    basic    neuropathologies    acoustics    things    frequencies    acquisition    insurance    preventatively    invasive    multispectral    groups    initial    markets    first    ing    mobile    health    rescue    diagnosis    version    global    billion    mobility    final    diagnosing    diagnostics    molecular    acceptance    validation    innovation    damage    clinics   

Project "UltraEASY" data sheet

The following table provides information about the project.

Coordinator		 SONOVUM AG 

Organization address
address: PERLICKSTRASSE 5
city: LEIPZIG
postcode: 4103
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Germany [DE]
 Project website http://www.sonovum.de
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SONOVUM AG DE (LEIPZIG) coordinator 50˙000.00

Map

 Project objective

Every 40 seconds, someone in Europe suffers from a stroke killing 1,000 Europeans daily. The resulting economic damage is immense. In the 2006 wake-up-study funded by the EU the economic damage in Europe amounts to 36 billion EUR per year. The objective of this project is the clinical validation of SoNovum AG’s UltraEASY™ II Brain Vitals Monitoring System and the underlying CAMUD technology for diagnosing and monitoring neuropathologies in acute events and at-risk patient groups. CAMUD stands for “Computer Aided Multispectral Ultrasound Diagnostics” and is a novel diagnostic method based on molecular acoustics. It measures the feedback of ultrasound waves on multiple frequencies, which is interpretable for the first time thanks to modern computer technology. The technology enables, among other things, a fast, very precise and non-invasive diagnosis of the brain tissue in the beginning of the therapeutic time frame as well as further, continuous monitoring. Therewith physicians will be able to diagnose acute events more quickly and preventatively at-risk patient groups, even before harmful incidents occur. Initial target market groups for UltraEASY II include the stroke units in clinics as well as family and specialist's practices in Europe with regard to global markets as well. Because of high mobility, flexibility and the small acquisition costs, it is well suited as basic equipment for practices as well as, in its mobile version, for helicopters, rescue vehicles and ambulances of clinics and emergency organizations. The objectives of this Feasibility Study are the examination of the market acceptance towards UltraEASY II, addressing clinics and physicians as well as involving patients, patient organizations and health insurance carriers, in order to conduct the risk evaluation for the final realization of the CAMUD technology in the MedTech sector and conclude the development of final innovation strategies for Phase 2.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ULTRAEASY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ULTRAEASY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More  

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More